WANG, YAN,王颖,王穎,PACHTER, JONATHAN A.,强那森Ａ 派许特,強那森Ａ 派許特,WANG, YAOLIN,王耀林,LIU, MING,刘明,劉明,强那森A 派许特,強那森A 派許特
申请号：
TW094142319
公开号：
TWI376233B
申请日:
2005.12.01
申请国别(地区):
TW
年份:
2012
代理人:
摘要：
The present invention provides methods for identifying patients whose cancers are likely to be responsive to IGF1R inhibitory anti-cancer therapy along with methods for treating such patients. Patients identified by a method of the present invention can be treated with any of several known IGF1R inhibitory agents including antibodies, small molecule inhibitors and anti-sense nucleic acids.本發明提供用作確認病患之癌症可能對IGF1R抑制性抗癌症療法有反應之方法與用以治療此病患之方法。可用數種已知IGF1R抑制性藥物包括抗體、小分子抑制劑及反意義核酸之任一者治療由本發明方法確認的病患。
